[Pe-033] English Poster Session 033「Neuroimmunology: NMOSD 2」

[Pe-033-4] Long-term safety and effectiveness of eculizumab in AQP4+ neuromyelitis optica spectrum disorder [Encore Presentation]

Jin Nakahara¹, Ichiro Nakashima², Hiroaki Yokote³, Yasuhiro Manabe⁴, Kazumi Okamura⁵, Kou Hasegawa⁵, Kazuo Fujihara^6,7
(1.Keio University School of Medicine, Japan, 2.Tohoku Medical and Pharmaceutical University, Japan, 3.Tokyo Metropolitan Komagome Hospital, Japan, 4.Okayama Central Hospital, Japan, 5.Alexion Pharma GK, Japan, 6.Fukushima Medical University, Japan, 7.Southern TOHOKU Research Institute for Neuroscience (STRINS), Japan
)